Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the changes in bone structure as determined by
magnetic resonance imaging measurements among early postmenopausal women after 24 months of
treatment with alendronate, 70 mg once a week as compared to placebo